Amryt Pharma creates and delivers innovative treatments to help patients with rare and orphan diseases live better lives.
Amryt Pharma has raised $125.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in February 2022.
Amryt Pharma's investors include European Investment Bank, Ares Management, Highbridge Capital Management, Athyrium Capital Management LP, Amati Global Investors.
Amryt Pharma is headquartered in Dublin, Ireland.
Amryt Pharma creates and delivers innovative treatments to help patients with rare and orphan diseases live better lives.
Amryt Pharma is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Amryt Pharma — Funding & Investors." VCBacked, February 22, 2022, https://www.vcbacked.co/company/amryt-pharma. Accessed August 13, 2026.
VCBacked. (2022). Amryt Pharma — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/amryt-pharma
{{cite web |title=Amryt Pharma — Funding & Investors |url=https://www.vcbacked.co/company/amryt-pharma |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated